Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation

Acta Diabetologica

Volumn 35, Issue 3, 1998, Pages 161-164

  Moro, E ^a   Zambon, C ^a   Pianetti, S ^a   Cazzolato, G ^a   Pais, M ^a   Bittolo Bon, G ^a  

^a Regional General Hospital   (Italy)

Author keywords

Atherosclerosis; Low density lipoproteins; Microalbuminuria; Non insulin dependent diabetes mellitus; Oxidation

Indexed keywords

ALBUMIN; ALKADIENE; COPPER ION; FRUCTOSAMINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LIPOPROTEIN METABOLISM; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ALBUMINURIA; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FRUCTOSAMINE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0031762409     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920050123     Document Type: Article

References (31)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035-2038
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr. cardiovascular mortality in men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444
3. Goldberg RB (1993) Lipid disorders in diabetes. Diabetes Care 4:561-572
4. Pyorala K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:121-141
5. Lorenzi M, Cagliero E, Toledo S (1985) Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 34:621-627
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL (1989) Beyond cholesterol: modifications of low-density lipoproteins that increased its atherogenicity. N Engl J Med 320: 915-924
7. Witzum JL, Steinberg D (1991) Role of oxidised low-density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792
8. Lyons TJ (1991) Oxidised low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabet Med 8: 411-419
9. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412
10. Sato Y, Hotta N, Sakamoto N, Matasuoka S, Ohishi N, Yagi K (1979) Lipid peroxide level in plasma of diabetic patients. Biochem Med 21:104-107
11. Velazquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF (1991) Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 8:752-758
12. Sanchez-Quesada JL, Perez A, Caixas A, Ordonmez-Llanos J, Payes A, Gonzales-Sastre F, de Leiva A (1996) Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia 39:1469-1476
13. Avogaro P, Bittolo-Bon G, Cazzolato G (1988) Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8:79-87
14. Avogaro P, Cazzolato G, Bittolo-Bon G (1991) Some questions concerning a small, more electronegative LDL circulating in human plasma. Atherosclerosis 91:163-171
15. Hodis H, Kramsch D, Avogaro P, Bittolo Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A (1994) Biochemical and cytotoxic characteristics of an in vivo circulating oxidised low density lipoprotein (LDL-). J Lipid Res 35:669-677
16. Sevanian A, Hwuang J, Hodis H, Cazzolato G, Avogaro P, Bittolo Bon G (1996) Contribution of an in vivo oxidised LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler Thromb Vasc Biol 16:784-793
17. Messent JW, Elliott TG, Hill RG, Jarret RJ, Keen H, Viberti GC (1992) Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three-year follow-up study. Kidney Int 41:836-839
18. Mattock MB, Morrish MJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:735-741
19. Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet ii:530-533
20. Collier A, Rumley A, Rummley AG, Petterson JR, Leach JP, Lowe GDO, Small M (1992) Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 41:909-913
21. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
22. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193:165-167
23. Kostner GM, Avogaro P, Bittolo-Bon G, Cazzolato G, Quinci GB (1979) Determination of high-density lipoproteins: screening methods compared. Clin Chem 25:939-942
24. Lehman S, Martin HL (1979) Improved direct determination of alpha- and gamma-tocopherols in plasma and platelets in liquid chromatography, with fluorescence detection. Clin Chem 28:1784-1788
25. Yagi K (1985) Assay for serum lipid peroxide level and its clinical significance. In: Yagi K (ed) Lipid peroxides in biology and medicine. Academic Press, New York, pp 223-242
26. Cazzolato G, Avogaro P, Bittolo-Bon G (1991) Characterisation of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med 11:247-253
27. Esterbauer H, Striegl G, Pukl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human LDL. Free Radic Res Commun 6:67-75
28. Wiseman MJ, Viberti GC, Mackintosh D, Jarrett RJ, Keen H (1984) Glycaemia, arterial pressure and microalbuminuria in type I (insulin-dependent) diabetesmellitus. Diabetologia 26:402-405
29. Dunn FL, Askin P, Bilheimer DW, Grundy SM (1984) The effect of diabetic control on very low density lipoprotein triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia. Metabolism 33:117-123
30. Tribble DL, Holl LG, Wood PD, Krauss RM (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189-199
31. Reaven PD, Herold DA, Barnett J, Edelman S (1995) Effect of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfraction to oxidation and on protein glycation in NIDDM. Diabetes Care 18:807-816